Clinical Trials List
Protocol NumberPB-102-F50
2018-07-01 - 2021-06-30
Phase III
Terminated1
ICD-10E78.2
Mixed hyperlipidemia
ICD-9272.2
Mixed hyperlipidemia
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 李星原 無
- Ting-Rong Hsu 無
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
30 participants
